Learning Objectives:
- Gut Microbes and microbial products regulate anti-tumor immunity by modulating the expression T-cell co-inhibitory molecules
- Targeting PD-L2/RGMb pathway can overcome microbiome-dependent resistance to immunotherapy
- RGMb is a novel inhibitory pathway for T cell responses to tumors
Session date:
01/22/2024 - 12:00pm to 1:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Jon Seok Park, PhD